But obesity therapeutics are moving very quickly, and clinicians increasingly need practical tools to translate changing trial evidence into everyday decision-making. Beyond Drug Choice: Nutrition, Function, and Psychology Obesity and dietitian societies also issued a new consensus statement at ECO 2026, calling for incretin-based obesity therapies such as GLP-1 receptor agonists to be integrated with dietetic, psychological, and functional support rather than used as stand-alone treatments
Theres no evidence they cause cancer, but elevated IGF-1 can accelerate existing cancer
Moreover, in the SNI-induced chronic neuropathic pain model, heat hyperalgesia was alleviated in mice challenged with SNI and administered intraperitoneal injections of 50 g of exendin 2029, with effects observed as early as 1 hour postadministration and peaking at 2 hours compared with those in the vehicle-administered group (Supplementary Fig
According to Article 2 of the EU Cosmetics Regulation, cosmetic products can only be used on the external parts of the human body, teeth, or mucous membranes of the oral cavity